309 related articles for article (PubMed ID: 27070129)
1. Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model.
Smith HL; Cheslock P; Leney M; Barton B; Molrine DC
Virulence; 2016 Aug; 7(6):660-8. PubMed ID: 27070129
[TBL] [Abstract][Full Text] [Related]
2. Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.
Sevigny LM; Booth BJ; Rowley KJ; Leav BA; Cheslock PS; Garrity KA; Sloan SE; Thomas W; Babcock GJ; Wang Y
Infect Immun; 2013 Nov; 81(11):3992-4000. PubMed ID: 23940209
[TBL] [Abstract][Full Text] [Related]
3. Characterization of serum anti-diphtheria antibody activity following administration of equine anti-toxin for suspected diphtheria.
Smith HL; Saia G; Lobikin M; Tiwari T; Cheng SC; Molrine DC
Hum Vaccin Immunother; 2017 Nov; 13(11):2738-2741. PubMed ID: 28933665
[TBL] [Abstract][Full Text] [Related]
4. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of different regimens of diphtheria serotherapy].
Matokhina AG; Kapustian VA; Perelygina OV
Zh Mikrobiol Epidemiol Immunobiol; 2010; (1):81-4. PubMed ID: 20218350
[TBL] [Abstract][Full Text] [Related]
6. [Comparative efficacy of homologous and heterologous biologicals against diphtheria].
Kapustian VA; Matokhina AG; Perelygina OV
Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):94-6. PubMed ID: 20465009
[TBL] [Abstract][Full Text] [Related]
7. [Identification of heterologous antitoxin in sera of patients with diphtheria].
Gal'vidis IA; Burkin MA; Sviridov VV
Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):47-9. PubMed ID: 19186546
[TBL] [Abstract][Full Text] [Related]
8. Human antibodies neutralizing diphtheria toxin in vitro and in vivo.
Wenzel EV; Bosnak M; Tierney R; Schubert M; Brown J; Dübel S; Efstratiou A; Sesardic D; Stickings P; Hust M
Sci Rep; 2020 Jan; 10(1):571. PubMed ID: 31953428
[TBL] [Abstract][Full Text] [Related]
9. Development of human monoclonal antibodies to diphtheria toxin: A solution for the increasing lack of equine DAT for therapeutic use?
Huygen K
Virulence; 2016 Aug; 7(6):613-5. PubMed ID: 27196732
[No Abstract] [Full Text] [Related]
10. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
Winsnes R; Sesardic D; Daas A; Behr-Gross ME
Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
[TBL] [Abstract][Full Text] [Related]
11. Suitability of the Vero cell method for titration of diphtheria antitoxin in the United States potency test for diphtheria toxoid.
Gupta RK; Higham S; Gupta CK; Rost B; Siber GR
Biologicals; 1994 Mar; 22(1):65-72. PubMed ID: 8068315
[TBL] [Abstract][Full Text] [Related]
12. Antidiphtheria antibody responses in patients and carriers of Corynebacterium diphtheriae in the Arkhangelsk region of Russia.
Danilova E; Jenum PA; Skogen V; Pilnikov VF; Sjursen H
Clin Vaccine Immunol; 2006 Jun; 13(6):627-32. PubMed ID: 16760319
[TBL] [Abstract][Full Text] [Related]
13. Access to diphtheria antitoxin for therapy and diagnostics.
Both L; White J; Mandal S; Efstratiou A
Euro Surveill; 2014 Jun; 19(24):. PubMed ID: 24970373
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of toxin neutralisation in test systems for diphtheria antibody assessment.
Vandenberg J; van der Gun JW; Hendriksen CF
Dev Biol Stand; 1999; 101():105-11. PubMed ID: 10566782
[TBL] [Abstract][Full Text] [Related]
15. Production of IgY polyclonal antibody against diphtheria toxin and evaluation of its neutralization effect by Vero cell assay.
Rezaeifard M; Solhi R; Mohammadi M; Abbasi E; Aminian M
BMC Biotechnol; 2021 May; 21(1):34. PubMed ID: 33980219
[TBL] [Abstract][Full Text] [Related]
16. [Mathematical model of the infection process in diphtheria for determining the therapeutic dose of antitoxic anti-diphtheria serum].
Kolibo DV; Romaniuk SI
Ukr Biokhim Zh (1999); 2001; 73(2):144-51. PubMed ID: 11642038
[TBL] [Abstract][Full Text] [Related]
17. The assay of diphtheria toxin.
GERWING J; LONG DA; MUSSETT MV
Bull World Health Organ; 1957; 17(4-5):537-51. PubMed ID: 13511133
[TBL] [Abstract][Full Text] [Related]
18. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation.
Sesardic D; Winsnes R; Rigsby P; Behr-Gross ME
Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263
[TBL] [Abstract][Full Text] [Related]
19. Delayed hypersensitivity. I. Induction of hypersensitivity to diphtheria toxin in guinea pigs by infection with Corynebacterium diphtheriae.
PAPPENHEIMER AM; UHR JW; YONEDA M
J Exp Med; 1957 Jan; 105(1):1-9. PubMed ID: 13385402
[TBL] [Abstract][Full Text] [Related]
20. [Study of diphtheria anatoxins in immunochemical and tissue culture assays].
Gal'vidis IA; Sviridov VV
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):28-32. PubMed ID: 17882833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]